Sotrovimab (Xevudy) – on hold

Sotrivimab (Xevudy) was listed on the Hospital Medicines List from 1 July 2022 in anticipation of supply being available soon.

The sotrovimab regulatory application with Medsafe is on hold while further evidence is collated. The future availability of sotrovimab is dependent on Medsafe approval.